Enzo Biochem Reports Across The Board Second Quarter 2014 Improved Results
Enzo Biochem Inc. (NYSE:ENZ) today reported across-the-board improved results for the fiscal second quarter ended January 31, 2014 as compared to the corresponding year-ago period.
•Total revenues improved 3%, with gains in Life Science and Clinical Labs, despite inclement winter weather that impacted laboratory revenues.
Help employers find you! Check out all the jobs and post your resume.